<HTML lang="en" dir="ltr" class="client-nojs">
<style type="text/css">
A:before { content:' '; } 
A:after { content:' '; } 
SPAN:before { content:' '; } 
SPAN:after { content:' '; } 
</style>
<BODY class="mediawiki ltr sitedir-ltr ns-0 ns-subject page-Team_Nagahama_BioBricks_for_medal skin-igem action-view"><DIV id="globalWrapper"><DIV id="content" class="mw-body" role="main"><DIV id="top_title"><H1 id="firstHeading" class="firstHeading"><SPAN dir="auto">Team:Nagahama/BioBricks for medal</SPAN></H1></DIV><DIV id="HQ_page"><DIV id="bodyContent"><DIV id="mw-content-text" lang="en" dir="ltr" class="mw-content-ltr"><DIV class="menu_wrapper"><DIV class="collapsable_menu_control"> MENU ▤ </DIV><UL id="accordion" class="accordion"><LI class="menu_item"><A href="https://2016.igem.org/Team:Nagahama">HOME </A></LI><LI class="menu_item"> PROJECT  
			</LI><LI><A href="https://2016.igem.org/Team:Nagahama/Introduction">   ・Introduction </A></LI><LI><A href="https://2016.igem.org/Team:Nagahama/Result and Discussion"> ・Result and Discussion </A></LI><LI><A href="https://2016.igem.org/Team:Nagahama/Future"> ・Future </A></LI><LI><A href="https://2016.igem.org/Team:Nagahama/Protocol"> ・Protocol </A></LI></UL><LI class="menu_item"> BioBricks  
			</LI><LI><A href="https://2016.igem.org/Team:Nagahama/Our all BioBricks">  ・Our all BioBricks </A></LI><LI><A href="https://2016.igem.org/Team:Nagahama/BioBricks for medal"> ・BioBricks for medal </A></LI><LI class="menu_item"><A href="https://2016.igem.org/Team:Nagahama/Safety"> Safety </A></LI><LI class="menu_item"> Attributions
			</LI><LI><A href="https://2016.igem.org/Team:Nagahama/Team">  ・Team</A></LI><LI><A href="https://2016.igem.org/Team:Nagahama/Attributions"> ・Attributions </A></LI><LI><A href="https://2016.igem.org/Team:Nagahama/Sponsors"> ・Sponsors</A></LI><LI class="menu_item"> Collaborations
			</LI><LI><A href="https://2016.igem.org/Team:Nagahama/Collaborations">  ・Collaborations</A></LI><LI><A href="https://2016.igem.org/Team:Nagahama/The Annual Meeting Of The Genetics Society Of Japan"> ・The Annual Meeting Of The Genetics Society Of Japan </A></LI><LI><A href="https://2016.igem.org/Team:Nagahama/Support Gifu"> ・Support Gifu</A></LI><LI><A href="https://2016.igem.org/Team:Nagahama/virginia">  ・Virginia</A></LI><LI><A href="https://2016.igem.org/Team:Nagahama/Paris-Saclay">  ・Paris-Saclay</A></LI><LI><A href="https://2016.igem.org/Team:Nagahama/Munich United"> ・Munich United</A></LI><LI class="menu_item"> Human Practice
			</LI><LI><A href="https://2016.igem.org/Team:Nagahama/Human Practice"> ・Human Practice </A></LI><LI><A href="https://2016.igem.org/Team:Nagahama/Contacting Local"> ・Contacting Local</A></LI><LI><A href="https://2016.igem.org/Team:Nagahama/Contacting Japan"> ・Contacting Japan</A></LI><LI><A href="https://2016.igem.org/Team:Nagahama/Intgrated Human Practice"> ・Intgrated Human Practice</A></LI><LI class="menu_item"><A href="https://2016.igem.org/Team:Nagahama/Proof of concept"> Proof of concept </A></LI><LI class="menu_item"><A href="https://2016.igem.org/Team:Nagahama/Demonstrate your work"> Demonstrate your work </A></LI></DIV><DIV class="content_wrapper">



BioBrick Parts to achieve each medal requirement
<P>Bronze

We created 3 new BioBricks [１ ](<A rel="nofollow" class="external free" href="https://2016.igem.org/Team:Nagahama/Our_all_BioBricks">https://2016.igem.org/Team:Nagahama/Our_all_BioBricks</A>) for bronze medal criterion. And have documented and submitted them to igem Registry.
We introduce yajo (<A rel="nofollow" class="external free" href="http://parts.igem.org/Part:BBa_K1950005">http://parts.igem.org/Part:BBa_K1950005</A>) of them. This biobrick is Key BioBrics in “Flavorator” project. Yajo encodes novel 1-deoxyxylulose-5-phosphate synthase. The novel 1-deoxyxylulose-5-phosphate synthase is able to synthesize 1-deoxy-D-xylulose 5-phosphate (DXP) from ribulose 5-phosphate, proving a novel route from a pentose phosphate to DXP 　Therefor the enzyme can catalyze  in the polyisoprenoid biosynthetic pathway. 
</P><P>Silver

We created 3 new BioBrick devices for silver medal criterion.

1.trc promoter + ispC-ribB(G108S) fusion

We want to make Escherichia coli synthesize a lot of farnesol, which is one kind of terpenes. We can achieve this purpose by fusing two genes, ispC and ribB(G108S).(<A rel="nofollow" class="external free" href="http://parts.igem.org/Part:BBa_K1950010">http://parts.igem.org/Part:BBa_K1950010</A>)
</P><DIV class="center"><DIV class="thumb tnone"><DIV class="thumbinner" style="width:139px;"><DIV class="thumbcaption">fig.1:Part:BBa_K1950010</DIV></DIV></DIV></DIV><P>
We tested whether the fusing gene was made by measuring ispC and ribB(G108S) transcription. The amounts of transcription were quantified by RT-RCR. In the fusion gene, ispC and ribB(G108S) are transferred from a single promoter. If two genes are fused successfully, two genes are expected to be higher in the recombinant than in WT.

2-1:PgpB.dev

2-2:YbjG.dev

To realize &quot;Flovorator&quot; we need to make E. coli produce Farnesol.
We have succeeded in confirming amount of transcription of PgpB.dev and YbjG.dev .
Our new biobrick device “PgpB.dev” and ”YbjG.dev” worked as expected. 
Because we validate this fact by RT-PCR analysis experimentally. We have documented and submitted this new Biobrick device (<A rel="nofollow" class="external free" href="http://parts.igem.org/Part:BBa_K1950007">http://parts.igem.org/Part:BBa_K1950007</A>)
(<A rel="nofollow" class="external free" href="http://parts.igem.org/Part:BBa_K1950008">http://parts.igem.org/Part:BBa_K1950008</A>) to iGEM Registry .
</P><DIV class="thumb tright"><DIV class="thumbinner" style="width:802px;"><DIV class="thumbcaption">fig.2:Part:BBa_K1950007_fig.3:Part:BBa_K1950008</DIV></DIV></DIV><P>
We want to make the E. coli produces farnesol which are one of the terpenes.
To produce great quantity of terpenes they need many terpene precursor and Farnesol synthase.
E. coli produces a small amount of the terpene precursor in MEP pathway.
In addition, E. coli has dephosphorylation enzyme of endogenous.
This is likely to synthesize farnesol from Farnesyl diphosphate (FPP), which is a precursor of farnesol.
In MEP pathway, there are four enzymes (ispD, ispF, idi, dxs) which are speed limiting enzyme for terpenes precursors produce in E. coli. 
Last year, in order to, create a high-yield strains producing IPP and DMAPP, we exogenously engineered to superimpose these genes into E. coli to create strains overproducing IPP and DMAPP.
This year, in order to generate a large amount of further farnesol, exogenously engineer genes coding for farnesol enzyme synthesis , YbjG and PgpB, as farnesol synthesis in E. coli. These are endogenous dephosphorylation enzyme of E. coli.
Farnesol is generated through FPP hydrolysis by PgpB and YbjG of endogenous phosphatases , which are induced by an increased intracellular FPP level.
To confirm whether the transcription of these genes is going well or not, we confirmed amount of the transcription of these genes by RT-PCR.
</P><P>Result:（fig◯）
</P><P>Discussion:
</P><DIV class="center"><DIV class="thumb tnone"><DIV class="thumbinner" style="width:622px;"><DIV class="thumbcaption">Fig4.The result of RT-PCR ybjG pgpB Fusion negative control</DIV></DIV></DIV></DIV><P>
Gold

marA :The activator of AcrAB-TolC multidrug efflux pump exports some terpenes
We improved the characterization of a previously existing BioBrick Part BBa_K1230000 and (<A rel="nofollow" class="external free" href="http://parts.igem.org/Part:BBa_K1230000">http://parts.igem.org/Part:BBa_K1230000</A>)　the characterization of a previously existing BioBrick marAgene as BBa_K1653006 . In existing part's information of marA, it gives E. coli resistance against kanamycin and give E-Coli resistance against geraniol as one of the terpene and decrease its intracellular concentration. In this year, we confirmed that overexpressing of marA gives E. coli resistance against farnesol as one of the terpene. This information is very beneficial for other iGEMers to production of toxic organic substances that are produced using bacteria. 
We introduce an activator gene of AcrAB-TolC efflux pump (MarA) to release the farnesol from the cells and increase the content in the media that shows increase these flavors in the &quot;Flavolator&quot;. In our study, we confirmed that overexpressing of marA gives host E. coli high resistance against farnesol.
</P><DIV class="center"><DIV class="thumb tnone"><DIV class="thumbinner" style="width:752px;"><DIV class="thumbcaption">Fig.5:Colony formation of E. coli JM109 engineered with marA on farnesol overlaid plates.  <I>E.coli</I> JM109 and <I>E.coli</I> JM109 (marA) were dropped on LBGMg agar plates in serial ten-fold dilutions (10⁻¹～〖10〗^(-6)), overlaid with 30 % (v/v)　farnesol hexane solution (farnesol solution) and incubated at 30°C for 24 h. This figure shows that <I>E.coli</I> JM109 (marA) cells that overexpress the marA product better than the control <I>E.coli</I> JM109 wild type cells survived plates overloyed by 30 % farnesol solution.</DIV></DIV></DIV></DIV><P>
Farnesol production device（<A rel="nofollow" class="external free" href="http://parts.igem.org/Part:BBa_K1653025）">http://parts.igem.org/Part:BBa_K1653025）</A></P><P>To realize &quot;Flovorator&quot; we need to make E. coli produce Farnesol. Surprisingly, last year, we have succeeded in farnesol production by Farnesol production device. Our previous biobrick device &quot;Farnesol production device&quot; worked as expected. Because we validated this fact by GC-MS analysis experimentally.
We confirmed expression level of genes used in the 2015 fiscal year project for reference of farnesol production increase.
We improved the characterization of a previously existing BioBrick Part BBa_K1653025
In existing part's information of farnesol production device, it gives E. coli farnesol production. In this year,
</P><P>This information is very beneficial for other iGEMers to farnesol that are produced using bacteria. 
</P><DIV class="thumb tright"><DIV class="thumbinner" style="width:736px;"><DIV class="thumbcaption">fig.6:Part:BBa_K1653025</DIV></DIV></DIV><P>
結果の図を入れる
</P></DIV></DIV></DIV></DIV></DIV></DIV></BODY></HTML>